Chlophedianol, dexchlorpheniramine, and pseudoephedrine and Tildrakizumab-asmn
Determining the interaction of Chlophedianol, dexchlorpheniramine, and pseudoephedrine and Tildrakizumab-asmn and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: chlophedianol / dexchlorpheniramine / pseudoephedrine
Brand name: Panatuss PED, Vanacof, Panatuss PED Drops
Synonyms: n.a.
Generic Name: tildrakizumab
Brand name: Ilumya
Synonyms: Tildrakizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Chlophedianol, dexchlorpheniramine, and pseudoephedrine-Tildrakizumab-asmn Subcutaneous
- Chlophedianol, dexchlorpheniramine, and pseudoephedrine-Tilia Fe
- Chlophedianol, dexchlorpheniramine, and pseudoephedrine-Tiludronate
- Chlophedianol, dexchlorpheniramine, and pseudoephedrine-Timentin
- Chlophedianol, dexchlorpheniramine, and pseudoephedrine-Timentin Add-Vantage
- Chlophedianol, dexchlorpheniramine, and pseudoephedrine-Timentin Injection
- Tildrakizumab-asmn-Chlophedianol, Dexchlorpheniramine, and Pseudoephedrine Drops
- Tildrakizumab-asmn-Chlophedianol, Dexchlorpheniramine, and Pseudoephedrine Liquid
- Tildrakizumab-asmn-Chlophedianol, Guaifenesin, and Phenylephrine Liquid
- Tildrakizumab-asmn-Chlophedianol, phenylephrine, and pyrilamine
- Tildrakizumab-asmn-Chlophedianol/Dexbrompheniramine/Phenylephrine Liquid
- Tildrakizumab-asmn-Chlophedianol/Guaifenesin Liquid